Publications
Poster
Effect of reduced D-Cloprostenol doses at progesterone device removal on reproductive performance in Nelore cows submitted to fixed-time artificial insemination
Adriel Vânio Gretter, Victor Guidi Zardo, Bruno Bernardino Versiani, Laís Angelo Abreu, Alexandre Hênryli de Souza, Rafael Moreira, Federico Randi, Pietro Sampaio Baruselli
Publication information
Word Buiatrics Congress 2026
Background and objective
It was hypothesized that a reduced dose of D-cloprostenol administered at progesterone device removal would not compromise pregnancy per AI in Nelore cows submitted to fixed-time artificial insemination (FTAI) protocols. The aim of this study was to evaluate whether a reduced dose of D- loprostenol (Luteglan®, Ceva Animal Health) administered at the time of progesterone device removal would affect pregnancy per AI in Nelore cows submitted to FTAI protocols.
Materials and Methods
Results
Conclusions
Reducing the dose of D-cloprostenol (Luteglan®, Ceva Animal Health) administered at progesterone device removal did not compromise follicular development, estrus expression, pregnancy per AI, or pregnancy maintenance in Nelore cows submitted to FTAI protocols. These findings support the use of the reduced dose as an effective alternative to the conventional dose under the conditions of this study.
Our booklet of abstracts brings together Ceva’s scientific contributions to the World Buiatrics Congress 2026.
Share this publication:
